Product Information
QUETIAPINE ER 300 MG TABLET is a generic product labeled by BluePoint Laboratories, priced at $0.2764 per EA under NDC 68001060106. Its NADAC has been published 141 times since Dec 13, 2023.
FDA first approved this application on Aug 15, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
300 mg/1
Manufacturer
BluePoint LaboratoriesNDC
68001060106
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
QUETIAPINE FUMARATEApproval Type
Generic (ANDA)
FDA Application
ANDA215478FDA Approved
8/15/2022
TE Code
AB
On Market Since
11/1/2023
Pharmacological Classes
Price Statistics
The NADAC for QUETIAPINE ER 300 MG TABLET has been published 141 times since Dec 13, 2023, and over the history we have for it it has risen 2.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2764 per EA |
|---|---|
| All-time high | $0.3119 (Apr 10, 2024) |
| All-time low | $0.1954 (Nov 20, 2024) |
| 52-week high | $0.2805 |
| 52-week low | $0.2559 |
| Median price | $0.2698 |
| Average price | $0.2671 |
| Largest weekly change | +47.7% (Aug 21, 2024) |
| Weeks tracked | 141 |
| Tracking since | Dec 13, 2023 |
Generic Alternatives
The matcher finds 10 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 54% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of QUETIAPINE ER 300 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for QUETIAPINE ER 300 MG TABLET, manufactured by BluePoint Laboratories, is $0.2764 per EA (NDC 68001060106), effective Aug 19, 2026.
How has the price of QUETIAPINE ER 300 MG TABLET changed over time?
Over the history we have for it, the NADAC for QUETIAPINE ER 300 MG TABLET has risen 2.6%. It has been tracked across 141 weekly CMS publications since Dec 13, 2023.
What are the highest and lowest recorded NADAC prices for QUETIAPINE ER 300 MG TABLET?
Since Dec 13, 2023, the NADAC for QUETIAPINE ER 300 MG TABLET has ranged from a low of $0.1954 (Nov 20, 2024) to a high of $0.3119 (Apr 10, 2024), with a median of $0.2698 per EA.
Are there cheaper alternatives to QUETIAPINE ER 300 MG TABLET?
Yes. 10 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, QUETIAPINE FUMARATE 300 MG TAB, is $0.1285 per EA — about 54% below QUETIAPINE ER 300 MG TABLET.
Who manufactures QUETIAPINE ER 300 MG TABLET?
QUETIAPINE ER 300 MG TABLET (NDC 68001060106) is labeled by BluePoint Laboratories, and CMS classifies it as a generic product.